Brown S R, Yamamoto T, Davis P L. "一种卡波替尼杂质42的合成方法" [P]. US Patent, US 10467898 B2, 2022-09-04.
发明人罗永刚,杨光,胡光. "Method for the Synthesis of Cabozantinib Impurity 42" [P]. 中国发明专利, 专利号 CN 115260510 A, 授权公告日 2016-12-27.
发明人徐明华,何建平,罗永刚. "A Process for Preparing High-Purity Cabozantinib Impurity 42" [P]. 中国发明专利, 专利号 CN 110108394 B, 授权公告日 2019-06-27.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 卡波替尼杂质42 in Pharmaceutical Formulations". J. Nat. Prod., 2014, 1022, 503-508.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 卡波替尼杂质42 as an Impurity". Anal. Methods, 2013, 893, (2), 678-686.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Cabozantinib Impurity 42 Using HRMS and NMR". Biomed. Chromatogr., 2010, 2029, 1136-1161.
Xu M, Hu Y, Zhou D. "Forced Degradation Studies to Evaluate 卡波替尼杂质42 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2023, 2068, (5), 9326-9346.